Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.134
-0.007 (-5.24%)
At close: Apr 28, 2026, 4:00 PM EDT
0.139
+0.005 (3.81%)
After-hours: Apr 28, 2026, 7:12 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.67 million as of April 28, 2026. Its market cap has decreased by -44.69% in one year.
Market Cap
2.67M
Enterprise Value
-263.99K
1-Year Change
-44.69%
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.67M, a decrease of -98.71%. That is a compound annual growth rate of -68.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.67M | 3.85% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 3.91M |
| Ensysce Biosciences | 3.84M |
| Artelo Biosciences | 3.79M |
| SciSparc | 3.78M |
| Azitra | 3.56M |
| GRI Bio | 3.35M |
| GeoVax Labs | 3.15M |
| Decoy Therapeutics | 2.89M |